Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Medpage Today on MSN5d
FDA Adds New Warning to GLP-1 DrugsLabels of all GLP-1 receptor agonists now carry a warning about pulmonary aspiration during general anesthesia or deep ...
GLP-1, SGLT2 medications may lower risk of future MI and repeat stroke among stroke survivors: Study
GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or ...
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...
As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new recommendations.
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...
News Medical on MSN2d
GLP-1, SGLT2 Drugs Cut Heart Risk for Stroke SurvivorsIn an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...
Hosted on MSN15h
Why's It So Hard to Get a GLP-1 Prescription?However, interest in GLP-1 drugs, particularly Ozempic, has also been fueled in part by social media discourse and ...
Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...
While GLP-1 RAs were prescribed for the relatively small number of patients with diabetes, he said, the risk was not apparent ...
GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback